Stay updated on Immunotherapy with TILs in Metastatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy with TILs in Metastatic Cancer Clinical Trial page.

Latest updates to the Immunotherapy with TILs in Metastatic Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedNew participant-focused sections and navigation were added, including Check who can join, Find Contact Information, How to Read a Study Record, Common Questions, How to Join a Study, and Intervention/Treatment. The page also shows date stamps (2026-06-10, 2026-06-11) and a Revision: v3.6.0, indicating a versioned update to the study page.SummaryDifference0.6%

- Check20 days agoChange DetectedNew revision v3.5.5 was released on 2026-06-05. The previous revision v3.5.4 was archived in May; this reflects routine documentation/version-control activity rather than substantive changes to the study content.SummaryDifference0.2%

- Check34 days agoChange DetectedTwo new timestamps were added (2026-05-22 and 2026-05-20) indicating recent updates to the study record; these appear to be metadata maintenance rather than changes to the study content.SummaryDifference0.2%

- Check41 days agoChange DetectedRevision: v3.5.4 was added and Revision: v3.5.3 was removed. This indicates a newer revision of the page's metadata.SummaryDifference0.0%

- Check55 days agoChange DetectedThe study record dates show new entries for 2026-04-28 and 2026-04-29 and removals for 2026-03-03 and 2026-03-04, indicating a revision of the record on those dates.SummaryDifference0.2%

- Check62 days agoChange DetectedThe page’s footer/version label has been updated from one software revision to the next (v3.5.2 to v3.5.3), indicating a site release rather than a change to the trial record.SummaryDifference0.0%

Stay in the know with updates to Immunotherapy with TILs in Metastatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy with TILs in Metastatic Cancer Clinical Trial page.